Company Filing History:
Years Active: 1977-1978
Title: Chester Rhodes Willis: Innovator in Pharmaceutical Compositions
Introduction
Chester Rhodes Willis is a notable inventor based in Kingston, Jamaica. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of asthma and related conditions. With a total of six patents to his name, Willis has demonstrated a commitment to advancing medical science through innovative solutions.
Latest Patents
Willis's latest patents include a method of treating asthma using 4,6-dihydroxy-2H-pyran-2-ones. This patent focuses on pharmaceutical compositions that comprise a substituted 4,6-dihydroxy-2H-pyran-2-one and methods for inhibiting the antigen-antibody reaction by administering these compositions. Another significant patent involves substituted 3-cinnamoyl-2H-pyran-2,6(3H)-diones, which also includes pharmaceutical compositions aimed at inhibiting the antigen-antibody reaction.
Career Highlights
Chester Rhodes Willis has built a successful career at Smithkline Corporation, where he has been instrumental in developing innovative pharmaceutical solutions. His work has not only contributed to the company's portfolio but has also had a positive impact on patient care and treatment options.
Collaborations
Throughout his career, Willis has collaborated with esteemed colleagues such as Kenneth M. Snader and Lawrence William Chakrin. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in pharmaceutical research.
Conclusion
Chester Rhodes Willis stands out as a dedicated inventor in the pharmaceutical industry. His innovative patents and collaborative efforts highlight his commitment to improving healthcare through scientific advancements.